Recommended Topic Related To:
Influenza A H1N1 Monovalent Vaccine
FDA Approves New Seasonal Flu Vaccine Made Using Novel Technology »
"The U.S. Food and Drug Administration today announced that it has approved Flublok, the first trivalent influenza vaccine made using an insect virus (baculovirus) expression system and recombinant DNA technology. Flublok is approved for the preve"...
Read the FDA Approves New Seasonal Flu Vaccine Made Using Novel Technology article »
Influenza A H1N1 Monovalent Vaccine
PATIENT INFORMATION
- Inform vaccine recipients or guardians that Influenza A (H1N1) 2009 Monovalent Vaccine contains killed viruses and cannot cause influenza.
- Inform vaccine recipients or guardians that there are two influenza vaccine formulations for this influenza season, the monovalent vaccine against influenza disease caused by pandemic (H1N1) 2009 virus and seasonal trivalent influenza vaccine.
- Instruct vaccine recipients or guardians to report any severe or unusual adverse reactions to their health care provider.
Last reviewed on RxList: 11/5/2009
This monograph has been modified to include the generic and brand name in many instances.
Next: Drug Description
Additional Influenza A H1N1 Monovalent Vaccine Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Women's Health
Find out what women really need.






